BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36134444)

  • 1.
    Goldberga I; Jensen ND; Combes C; Mentink-Vigier F; Wang X; Hung I; Gan Z; Trébosc J; Métro TX; Bonhomme C; Gervais C; Laurencin D
    Faraday Discuss; 2023 Jan; 241(0):250-265. PubMed ID: 36134444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium pyrophosphate crystal deposition: a kinetic study using a type I collagen gel model.
    Mandel GS; Halverson PB; Rathburn M; Mandel NS
    Scanning Microsc; 1990 Mar; 4(1):175-9; discussion 179-80. PubMed ID: 2164257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium pyrophosphate crystal deposition. An in vitro study using a gelatin matrix model.
    Mandel NS; Mandel GS; Carroll DJ; Halverson PB
    Arthritis Rheum; 1984 Jul; 27(7):789-96. PubMed ID: 6331461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the calcium pyrophosphate monohydrate phase (Ca2P2O7·H2O): towards understanding the dehydration process in calcium pyrophosphate hydrates.
    Gras P; Ratel-Ramond N; Teychéné S; Rey C; Elkaim E; Biscans B; Sarda S; Combes C
    Acta Crystallogr C Struct Chem; 2014 Sep; 70(Pt 9):862-6. PubMed ID: 25186358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium pyrophosphate crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP; Adams ME; Nyburg SC; Omar SA
    J Rheumatol; 1980; 7(5):609-16. PubMed ID: 6255159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for human calcium pyrophosphate crystal deposition disease: crystallization kinetics in a gelatin matrix.
    Mandel NS; Mandel GS
    Scan Electron Microsc; 1984; (Pt 4):1779-92. PubMed ID: 6098005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of monoclinic calcium pyrophosphate dihydrate (m-CPPD) involved in inflammatory reactions and osteoarthritis.
    Gras P; Rey C; André G; Charvillat C; Sarda S; Combes C
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2016 Feb; 72(Pt 1):96-101. PubMed ID: 26830800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From crystalline to amorphous calcium pyrophosphates: A solid state Nuclear Magnetic Resonance perspective.
    Gras P; Baker A; Combes C; Rey C; Sarda S; Wright AJ; Smith ME; Hanna JV; Gervais C; Laurencin D; Bonhomme C
    Acta Biomater; 2016 Feb; 31():348-357. PubMed ID: 26476341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of calcium and magnesium ions on calcium pyrophosphate crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP
    J Rheumatol; 1981; 8(5):772-82. PubMed ID: 6273554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium pyrophosphate crystal deposition: the effect of soluble iron in a kinetic study using a gelatin matrix model.
    Mandel GS; Halverson PB; Mandel NS
    Scanning Microsc; 1988 Jun; 2(2):1177-88. PubMed ID: 2840734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Density functional geometry optimization and energy calculations of calcium(II)-triphosphate complexes. Polyphosphates as possible dissolving agents for calcium pyrophosphate dihydrate crystals in chondrocalcinosis disease.
    Cini R; Chindamo D; Catenaccio M; Lorenzini S; Marcolongo R
    J Biomol Struct Dyn; 2000 Aug; 18(1):155-68. PubMed ID: 11021660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium pyrophosphate dihydrate crystal formation in model hydrogels.
    Pritzker KP; Cheng PT; Adams ME; Nyburg SC
    J Rheumatol; 1978; 5(4):469-73. PubMed ID: 216804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate Relies on NF-κB Activation and MAPK Pathways.
    Campillo-Gimenez L; Renaudin F; Jalabert M; Gras P; Gosset M; Rey C; Sarda S; Collet C; Cohen-Solal M; Combes C; Lioté F; Ea HK
    Front Immunol; 2018; 9():2248. PubMed ID: 30356764
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of glycosaminoglycans on calcium pyrophosphate crystal formation in collagen gels.
    Hunter GK; Grynpas MD; Cheng PT; Pritzker KP
    Calcif Tissue Int; 1987 Sep; 41(3):164-70. PubMed ID: 2822212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of monoclinic calcium pyrophosphate dihydrate crystals with neutrophils.
    Winternitz CI; Jackson JK; Burt HM
    Rheumatol Int; 1996; 16(3):101-7. PubMed ID: 8893374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium pyrophosphate crystal deposition in model systems.
    Mandel N; Mandel G
    Rheum Dis Clin North Am; 1988 Aug; 14(2):321-40. PubMed ID: 2845492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the beta form of calcium pyrophosphate tetrahydrate.
    Balić-Zunić ; Christoffersen MR; Christoffersen J
    Acta Crystallogr B; 2000 Dec; 56 ( Pt 6)():953-8. PubMed ID: 11099960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium pyrophosphate crystal deposition: the effect of monosodium urate and apatite crystals in a kinetic study using a gelatin matrix model.
    Mandel GS; Halverson PB; Mandel NS
    Scanning Microsc; 1988 Jun; 2(2):1189-98. PubMed ID: 2840735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and membranolytic effects of triclinic calcium pyrophosphate dihydrate crystals.
    Burt HM; Jackson JK
    J Rheumatol; 1987 Oct; 14(5):968-73. PubMed ID: 2828618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium pyrophosphate dihydrate (CPPD) crystal dissolution by alkaline phosphatase: interaction of alkaline phosphatase on CPPD crystals.
    Shinozaki T; Xu Y; Cruz TF; Pritzker KP
    J Rheumatol; 1995 Jan; 22(1):117-23. PubMed ID: 7699658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.